USPTO trademark

RAPIBLYK

RegisteredUSPTOWord markClass 5

"RAPIBLYK" is a word mark owned by AOP Orphan Pharmaceuticals GmbH, filed at the USPTO on June 6, 2024. It is registered and covers class 5 (Pharmaceuticals).

View AOP Orphan Pharmaceuticals GmbH portfolioGet this data via the API
Official USPTO record
RAPIBLYK trademark as filed
As filed with the USPTO
Status
Registered
Since December 2, 2025
Filed
June 6, 2024
Registered
December 2, 2025
Expires
Not recorded
Application no.
98589242
Registration no.
8053635
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns RAPIBLYK

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

AOP Orphan Pharmaceuticals GmbH

Vienna, Austria

48 trademarks in the portfolioView company

Representative

Michael Fedrick

Loza & Loza, LLP

Goods and services

What the mark covers

The products and services RAPIBLYK is filed for, grouped by Nice class.

  • Pharmaceutical and veterinary preparations, namely, cardiovascular treatment preparations acting on the cardiovascular system and CNS; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of tachyarrhythmias, tachycardias and atrial fibrillation; pharmaceutical preparations for the emergency treatment of tachyarrhythmias, tachycardias and atrial fibrillation

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Notice of acceptance of statement of use e-mailed
  4. Allowed principal register - sou accepted
  5. Statement of use processing complete
  6. Case assigned to intent to use paralegal
  7. Use amendment filed
  8. Teas statement of use received
  9. Noa e-mailed - sou required from applicant
  10. Official gazette publication confirmation e-mailed

6 earlier steps on the official record.

FAQ

About RAPIBLYK

Who owns the trademark "RAPIBLYK"?

The USPTO trademark "RAPIBLYK" (application 98589242) is owned by AOP Orphan Pharmaceuticals GmbH.

What is the status of "RAPIBLYK"?

Its status at the USPTO is: registered.

When was "RAPIBLYK" registered?

It was registered on December 2, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RAPIBLYK and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d292e-c023-748a-b548-b30f4be60804
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d292e-c023-748a-b548-b30f4be60804",
  "object": "trademark",
  "mark_text": "RAPIBLYK",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98589242",
  "filing_date": "2024-06-06",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "AOP Orphan Pharmaceuticals GmbH",
      "entity_id": "ent_019eb70a-c158-70ef-b5ae-7514e3f1abd5"
    }
  ]
}